chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came in for Janssen COVID-19 first dose. Patient was called into the immunization area and date of birth and vaccination verification was completed. Patient was given the vaccine and was feeling fine. He was instructed to sit in the waiting area for at least 15 minutes to make sure he was feeling okay before leaving. Patient proceeded to sit in the waiting area. After approx. 2 to 3 minutes he walked up to the pick-up area and stated to the technician he felt like he was about to pass out. He was immediately instructed by the pharmacist to sit. She told the technicians to grab water and a cold compress while she went out to check the patient. He proceeded to sit and stated he felt as if he was going to throw up. A trach can was obtained and given to the patient. A cold compress was placed on the patient's neck and he was given a water. He requested a pop to which he was given a Coke. He then proceeded the vomit into the trash can while the pharmacist observed to make sure he did not have any further issues. The patient then stated after another minute that he felt much better. He continued to drink the Coke and was observed closely. After approx. 25 minutes he insisted he was feeling much better and wanted to leave  and was allowed to by the pharmacist. No further issues were reported.
Severe headache, fever 101.1, dizzy, severe body aches, chills, fatigue
Chills, Fever, Body Aches, Headache happened within 6 hours of getting the vaccine and lasted for 36 hours.
Pt received FLUMIST on 1/21/14 and developed nasal cellulitis on 1/26/14 and was treated.
Patient was diagnosed with breast cancer 8 months after receiving her first dose of COVID 19 vaccine.  She has received the second dose and booster.  Her sister developed pancreatic cancer 11 months after receiving the COVID 19 vaccine.  Both pt. and her sister are BCRA 2 pathogenic mutation positive.
Date of Admission:  11/10/2021   Chief Complaint:  Shortness of breath   Source of Information:  Patient   History of Present Illness:  This is a 57y.o. male with PMH of HFrEF, anxiety, HTN, HLD, gout, A-fib with pacer placement, chronic lymph edema, osteoarthritis of various lower extremity joints presents to BFH ED c/o shortness of breath with incidental COVID positive test. He currently O2 sat of 99% on room air. He has received two COVID vaccination shots. He lives with his brother and sister who are both also vaccinated, but his brother also tested positive today. Pt states that he started having a dry cough three days ago, then lost his voice due to the severe coughing two days ago. He notes that hot food makes it better and dry food makes it worse. He felt that he couldn't "catch his breath" last night 11/9/21 around 9 pm and started banging his walking stick to get his sister's attention in order to take him to the ED. He notes that he struggles with anxiety and often has panic attacks, so the shortness of breath made his anxiety worse. He was recently admitted 10/6/2021 for acute CHF exacerbation where medications were changed and pt expresses concern about medication changes. Admits he does use compression pumps at home for his chronic lymphedema that he notes is improved compared to his baseline, but has not used the lymphedema pumps over the past week. He denies tobacco usage and only reports occasional social EtOH drinking, no recreational drug usage. No significant family history
About 1 minute after getting the vaccine patient lightheaded and dizzy and fell off the chair and fell to the floor patient did have a loss of  conscious  witnessed by staff. Patient was placed on a backboard and was transported to the medical observation area. vital signs on arrival was 103/70, follow up bp was 105/71 HR 88 and pulse ox 98%  . EMS was contacted due to loss of conscious and falling and hitting her head, final blood pressure was 108/69 . EMS arrived and transported patient to the hospital, husband was with patient and left with patient
Pain and stiffness in upper arm that persisted for over 1 month, could not raise arm over over height, could not sleep on left side due to pain,  it 's now 12/4/2013 and slowly getting better.  Still some soreness.  Please see website on link, many people have the same complaint, my opinion is the issue is with the injection was placed incorrectly on the arm. Is this condition considered SIRVA? Mine was done at a free clinic. I think student nurses did the shot administration so maybe additional training and supervision is needed.  I never had a problem in the past (other than a day or 2 soreness). If this problem happens enough I would think people who are hesitant to begin with will not get a shot in the future.
Pain, swelling, itchy, hot to touch, ice pack, Ibuprofen.
Dehydration; High blood pressure; Fever 98.1 degrees fahrenheit); This spontaneous case was reported by an other caregiver and describes the occurrence of DEHYDRATION (Dehydration) and HYPERTENSION (High blood pressure) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D NOS for an unknown indication.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In May 2021, the patient experienced DEHYDRATION (Dehydration) (seriousness criterion hospitalization prolonged) and HYPERTENSION (High blood pressure) (seriousness criterion hospitalization prolonged). On 01-Jun-2021, the patient experienced PYREXIA (Fever 98.1 degrees fahrenheit)   ). The patient was hospitalized for 3 days due to DEHYDRATION and HYPERTENSION. The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 tablet. At the time of the report, DEHYDRATION (Dehydration), HYPERTENSION (High blood pressure) and PYREXIA (Fever 98.1 degrees fahrenheit)   ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment received while hospitalized was not reported.  Company comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
It was not an adverse affect ,  Tdap is accidently given instead of Dtap.  Baby left the clinic fine yesterday and mom did not call back regarding any issues. Nurse only realize it today when someone brought it to her attention. She immediately notified the DR. The DR will call mom to make aware
Diagnosed with COVID 19 - fever, chills, body aches, congested sinuses, nasal discharge, sneezing, coughing
Saturday, 2 October 2010:  9:30 am - "Super" flu shot at Clinic (combined H1N1 and regular flu)  2:45 pm - Attending event, about 2 blocks from home. Began to feel weak, slightly dizzy, and slightly nauseous. Fingertips numb. Walked home, feeling progressively worse. Starting to shiver.  3:00 pm - Lay down on bed with blanket. Shivering worse. Numbness reached 1st finger joints.  3:30 pm - Shivering continued. Numbness reached second finger joints.  4:50 pm - Wife returns. Adds blankets. Gets out blood-pressure cuff and thermometer.  5:00 pm - Still in bed. Most symptoms greatly reduced or gone.    Blood pressure: 160/90 (both abnormally high). Temperature: 101.5    Pulse rate: 105 (extremely high, for me, Normal is about 60.)  9:00 pm -Still in bed. All symptoms gone.    Blood pressure: 130/80 (approximately normal). Temperature: 100    Pulse rate: 80 (still unusually high) Was able to eat a small supper.     Comment: Since the first measurement of pulse rate was made after the symptoms had either disappeared or receded greatly, it is likely that at the peak of the symptoms my pulse rate was even higher that 105, possibly considerably higher.     Sunday, 3 October 2010:  9:00 am - All symptoms gone.    Blood pressure: 105/62 (a bit low). Temperature: 98.4    Pulse rate: 60 (normal)     Monday, 4 October 2010:  8:30 am - Attended exercise class. Still feeling a bit
Headache s,lungs with flem in the morning s.low energy levels.flucuating blood pressure.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 52-year-old male patient who received FLUARIX QUADRIVALENT (batch number 23L7C, expiry date unknown). Previously administered products included flu vaccine (received in last year). On 9th January 2017, the patient received the 1st dose of FLUARIX QUADRIVALENT (intramuscular). On 10th January 2017, 1 days after receiving FLUARIX QUADRIVALENT, the patient experienced injection site pain (serious criteria hospitalization and disability). On 12th January 2017, the patient experienced mobility decreased (serious criteria hospitalization and disability), weakness of arms (serious criteria hospitalization and disability), numbness (serious criteria hospitalization and disability) and sleep disturbance. On an unknown date, the outcome of the injection site pain, mobility decreased, weakness of arms and numbness were recovering/resolving and the outcome of the sleep disturbance was unknown. The reporter considered the injection site pain, mobility decreased, weakness of arms and numbness to be related to FLUARIX QUADRIVALENT. It was unknown if the reporter considered the sleep disturbance to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: This case was reported by an Occupational Health Nurse with the disability Management group at GSK, who was notified via the phone, by another GSK employee (patient) he had a reaction to the GSK FLUARIX vaccine. The case was previously reported to a doctor. The patient informed the nurse on 1st June 2017 via telephone that he had initial soreness at the injection site on 10th January 2017. The patient accessed the emergency room. On 11th January 2017, it became pain that was severe in his right arm down to his elbow, across the back of his shoulder, neck and upper left shoulder and arm. On 12th January 2017, the pain worsened in the identified areas and extended on both sides of his lateral dorsi, impacting his sleep, limited ability to lift items more than 4 or 5 pounds with his arms and wrists, he also complained of numbness in his wrists. The patient had been unable to return to work. On 21st January 2017, he did note improvement in the symptoms, however limited mobility and weakness in his arms and wrists remained. It was also noted that the patient had received the flu vaccine in previous years, but unknown if it was FLUARIX. The patient had reported these events to his physician. At the time of reporting, the patient (employee) was on leave with GSK. The reported batch number (2317C) of FLUARIX QUADRIVALENT did not exist and was updated to 23L7C as per sales database.
Nausea; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a patient family member or friend and describes the occurrence of NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea) (seriousness criterion hospitalization) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, NAUSEA (Nausea) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.            No concomitant medications were reported. Treatment details included unspecified medications for nausea.  Very limited information regarding the events has been provided at this time.  Further information has been requested.   This case was linked to MOD-2021-254067 (Patient Link).   Reporter did not allow further contact; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
03/02/2022 I had a little bit of a low grade fever. I felt a little odd, did not feel very well. I was not nauseated, but was not hungry. Weird appetite for a day or so.
Full blown cold with sour throat, chills, cough  and off the chart blood pressure and heart rate!! Took 3 days to be some what better, but cough is still with me.
fever for 2 days, treated with Tylonol; headache for 4 days treated with Aleve or Tylonol; severe malaise for 3 days treated with bed rest; moderate to severe toothaches treated with Tylonol and Aleve; severe fatigue for 7 days treated with rest at first and then mild exercise; fatigue continues
Localized reaction of redness and swelling at sight of DTAP injection. No systemic reaction.
not feeling good at all; staying in bed; throwing up; aching,pain; fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling good at all), SOMNOLENCE (staying in bed), VOMITING (throwing up), MYALGIA (aching,pain) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (not feeling good at all), SOMNOLENCE (staying in bed), VOMITING (throwing up), MYALGIA (aching,pain) and PYREXIA (fever). The patient was treated with ACETAMINOPHEN at a dose of UNK, q8h. At the time of the report, FEELING ABNORMAL (not feeling good at all), SOMNOLENCE (staying in bed), VOMITING (throwing up), MYALGIA (aching,pain) and PYREXIA (fever) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up information received on 23-JUN-2021 and contains significant information. Updated treatment information
This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 19-year-old female patient who received ENGERIX B for prophylaxis. On an unknown date, the patient received ENGERIX B 1 ml. On an unknown date, unknown after receiving ENGERIX B, the patient experienced inappropriate age at vaccine administration, lack of drug effect, therapy non-responder and hepatitis B antibody negative. On an unknown date, the outcome of the inappropriate age at vaccine administration, lack of drug effect, therapy non-responder and hepatitis b antibody negative were unknown. It was unknown if the reporter considered the inappropriate age at vaccine administration, lack of drug effect, therapy non-responder and hepatitis b antibody negative to be related to ENGERIX B. Additional details were provided as follows: The nurse reported that the patient received 1ml of ENGERIX B when 0.5 ml was indicated for her age group, which led to inappropriate age at vaccine administration. The reporter also stated that they had to restart the series due to nonreactive lab work. Lab Comments: Lab test performed on an unknown date.
Pt had elevated temp 22FEB91 x 3 days (101.2)R 1x when mom checked temp; low grade temp during day & elevated more @ night. On 24FEB91 broke out w/rash all over. Raised bumps which turned to large whelps if got hot. Seen by MD 26FEB91.
This client reports swelling and severe aching in the joints of feet knees, hands, wrists, and elbows. Beginning on 07/13/2001 and severe enough on 07/18/01, could hardly walk. She saw a doctor, and had several test. The doctor thought it was a reaction due to the TD vaccine. The client is completely healed on 07/22/01 at church.
Headache Weakness Slight fever not exceeding 100.5 Body aches Irritability Hot and cold flashes Tiredness Started the next day after injection and lasted until Sunday morning 5/16 around 10am.
Patient had a seizure. She stood up. Her eyes rolled back into her head. Her body went rigid.  She fell over. She was completely blacked out for one minute. When she regained consciousness, she could not stand with out falling, nor could she have a conversation. She was transported by ambulance to the emergency room.
Vaccine Monday morning. Dizziness and headache by Thursday night at 8 pm. Dizziness Friday morning and afternoon so far.
Information has been received from a physician concerning a 4 month old female who on 15-JAN-2008 was vaccinated PO with a 2.0 ml dose of Rotateq.  Concomitant vaccinations administered that same day included other "most common injectable vaccines used."  On that same day the patient experienced diarrhea (stool green in color) and stomach pains.  It was unknown whether medical attention was sought.  The patient's mother requested to discontinue therapy with Rotateq.  The outcome was unknown.  There was no product quality complaint.  Additional information has been requested.
Pain at site - same day unable to lift arm - 7/27-7/30. Swelling and rash 7/27-8/1 on arms and shins. Headache 7/27-7-29, tiredness 7/27-7/29. Nausea 7/27. Swollen lymph glands, hoarseness 7/28-7/31.
PT COMPLAINED OF "DISCOMFORT IN THROAT". GAVE PT WATER AND TOOK VITAL SIGNS, BP 148/82, HR 78, O2 98%, TEMP 98.6 F. STILL COMPLAINED OF SLIGHT DISCOMFORT SO GAVE PT 25MG OF BENADRYL.CONTINUED TO MONITOR AND RETOOK VITAL SIGNS BP 132/80, HR 79, O2 98%, TEMP 98.4 F. PT STATED " I FEEL BETTER".
This case was reported by a physician via sales rep and described the occurrence of fever in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever. On an unknown date, the outcome of the fever was unknown. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received SHINGRIX at outside of reporter's office and experienced fever. The reporter had limited information.
Patient is 4 weeks pregnant at time of vaccine. She received vaccine on 10/20/2020 at 11am. On Wednesday 10/21/2020 she began to have a rash break out on her body that was red and "itchy". Patient presented to clinic with rash on Thursday 10/22/2020. Physician's Assistant evaluated patient and determined it was necessary to provide patient with an antihistamine mediation as well as topical Benadryl.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021 at 2:53 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021 at 2:53 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 21.20.  Concomitant products were not provided.  Excursion time was 09 AM and 10 AM, the temperature was 34 and 37 respectively. Total doses given for the day was 184, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Mar-2021, vial was moved to clinic on 20-Mar-2021. 19 vials were sent to clinic. Vaccine BUD date was 08-Apr-2021.  Vial was stored on cooler 1, on 20-Mar-2021, Excursion duration at 9 AM: 34, 10 AM: 30, 11 AM: 41, 12 AM: 45, 1PM: 44, 2 PM : 44, 3 PM: 44, 4 PM: 44 and 5 PM : 43.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
FEELING SLEEPY; FEELING  TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020,expiry: UNKNOWN) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced feeling sleepy. On 29-MAR-2021, the subject experienced feeling tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feeling sleepy, and feeling tired on 31-MAR-2021. This report was non-serious.
Information has been received from a physician concerning a 17 or 18 year old female who was vaccinated with Gardasil. Subsequently, the patient experienced delayed menstrual cycle after receiving Gardasil. The physician advised the patient to contact her after one month if she still did not have a menstrual cycle. Additional information has been requested.